Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 808

1.

Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.

Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Lin H, Pan CX, Tretiakova M, Baldridge LA, Cheng L.

Hum Pathol. 2005 Jul;36(7):718-23.

PMID:
16084939
2.
3.

Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.

Agoff SN, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD, Folpe AL.

Mod Pathol. 2000 Mar;13(3):238-42.

4.

P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.

Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, Koch MO, Lin H, Baldridge LA, Tretiakova M, Cheng L.

Anticancer Res. 2005 May-Jun;25(3B):2001-4.

6.
7.

Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.

Fernández-Aceñero MJ, Córdova S, Manzarbeitia F, Medina C.

Pathol Oncol Res. 2011 Sep;17(3):519-23. doi: 10.1007/s12253-010-9341-z. Epub 2011 Jan 4.

PMID:
21203907
11.

Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution.

Alijo Serrano F, Sánchez-Mora N, Angel Arranz J, Hernández C, Alvarez-Fernández E.

Am J Clin Pathol. 2007 Nov;128(5):733-9.

PMID:
17951193
12.

Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.

Rossi G, Cavazza A, Sturm N, Migaldi M, Facciolongo N, Longo L, Maiorana A, Brambilla E.

Am J Surg Pathol. 2003 Mar;27(3):311-24.

PMID:
12604887
15.
16.

[Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].

Wang CL, Yue DS, Zhang ZF, Zhan ZL, Sun LN.

Zhonghua Yi Xue Za Zhi. 2007 Sep 4;87(33):2350-4. Chinese.

PMID:
18036300
17.
18.

Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.

Puglisi F, Barbone F, Damante G, Bruckbauer M, Di Lauro V, Beltrami CA, Di Loreto C.

Mod Pathol. 1999 Mar;12(3):318-24.

PMID:
10102618
19.

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J, Cheney R, Wiseman S, Anderson T, Loewen G.

Hum Pathol. 2003 Jun;34(6):597-604.

PMID:
12827614
20.

Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.

Pelosi G, Fraggetta F, Pasini F, Maisonneuve P, Sonzogni A, Iannucci A, Terzi A, Bresaola E, Valduga F, Lupo C, Viale G.

Am J Surg Pathol. 2001 Mar;25(3):363-72.

PMID:
11224607

Supplemental Content

Support Center